HEALTHCARE

GrayMatters received US FDA approval for marketing its technology in March and after the start of the Israel-Hamas war received approval in Israel.

Nestlé says the trial results did not meet the full minimal terms set in the licensing agreement.

The Swiss bank sees the Israeli pharmaceutical company transitioning to a more brand-focused company.

A previous deal with US company Bioventus fell through. Israeli company CartiHeal has developed an implant for treating cartilage and joint surface lesions in the knee.

IDF Spokesperson: IDF medical teams together with Arabic speaking soldiers are present in the area in order to ensure that the equipment reaches those that need it.

With Gaza's hospitals like Shifa acting as terrorist strongholds and needing to be evacuated, "Globes" examines solutions to the crisis.

The funding agreement will offset program costs for Teva, which will lead the clinical development of the schizophrenia treatment and regulatory process and is responsible for commercialization.

The new funds will help the company develop AI solutions for group therapy sessions, compliance automation, case management, concurrent documentation and value-based care support.

The Israeli pharmaceutical company will return to revenue growth after five years in which its revenue has shrunk.

Under the terms of the collaboration agreement, Teva will receive an upfront payment of $500 million and up to $1 billion in development and launch milestones.

The new funds will be used for US commercialization of the BioProtect Balloon Implant System, which recently received FDA clearance for rectal protection during radiation therapy for prostate cancer.

Richie Hunter's Green Lantern has made three times its investment in the fitness club chain.

TytoCare CEO Dedi Gilad: The collaboration combines our advanced telemedicine solutions with Sompo's commitment to making healthcare services accessible to the Japanese market.

The Israeli biopharmaceutical company's CEO Philip Serlin told "Globes" that the product will be ready for marketing in a few weeks.

The Ministry of Health reports that 136 people tested positive yesterday compared with an average of 74 at the start of September but this is the tip of the iceberg.

The Israeli company is transforming cancer diagnostics with AI-powered solutions that help pathologists improve the quality of diagnosis and support laboratories with enhanced efficiency and better turnaround times.

The Israeli company has developed a pill that swells in the stomach, creates a sense of satiation and then disintegrates.

The Innovation Authority and Finance Ministry delegation will study the Boston tech eco-system and consider incentives for US investment funds.

The Israeli company has developed FDA approved autonomous robots for performing hands-free surgery but has failed to generate significant revenue.

The Israeli company claims that its groundbreaking technology can predict trial outcomes with 86% accuracy.

The Israeli company has developed AI companion ElliQ, which is designed to enhance the lives of older adults by easing loneliness and promoting healthier and independent living.

As Israel faces a doctor shortage, Reichman University is establishing a new, NIS 90,000-a-year medical school, attracting scorn and skepticism.

Regulatory changes by the Ministry of Health are expected to save NIS 90 million annually.

ReWalk has completed the acquisition of AlterG, which provides anti-gravity systems for use in physical and neurological rehabilitation.

Ministry of Health director general Moshe Bar Siman Tov has instructed the health funds to ignore a directive from the Capital Markets, Insurance and Savings Authority.

TytoCare, which develops and markets remote diagnostic devices, raised the money at a higher company valuation, despite the dip in the telehealth market.

The Israeli pharmaceutical company beat the analysts' expectations in the second quarter of 2023 with revenue of $3.9 billion and non-GAAP earnings per share of $0.56.

EssilorLuxottica plans developing lenses in which Nuance's acoustic beamforming technology is embedded and launching the eyeglasses next year.

The city is teeming with rats feasting on garbage and sewage in its overcrowded neighborhoods. The municipality, which is finally taking action, blames light rail works.

The Israeli-founded company also published a research article comparing the performance of its AI platform to that of doctors.